Differences between commercial vehicle drivers and other patients in symptoms of obstructive sleep apnoea and response to CPAP therapy

W. Strobel, D. Stolz, M. Tamm (Basel, Switzerland)

Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Session: CPAP: beneficial effects on different aspects of health
Session type: Poster Discussion
Number: 439
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Strobel, D. Stolz, M. Tamm (Basel, Switzerland). Differences between commercial vehicle drivers and other patients in symptoms of obstructive sleep apnoea and response to CPAP therapy. Eur Respir J 2012; 40: Suppl. 56, 439

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018


Telecoaching to improve physical activity in patients with obstructive sleep apnea treated with CPAP
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 97s
Year: 2003

Reported but not measured sleep latency predicts successful CPAP therapy in patients with obstructive sleep apnoea
Source: Eur Respir J 2002; 20: Suppl. 38, 101s
Year: 2002

Is the daily duration of nasal CPAP ventilation the main determinant of improvement of blood gases in OSAS (obstructive sleep apnoea syndrome) patients?
Source: Eur Respir J 2001; 18: Suppl. 33, 390s
Year: 2001

Menopausal status and severity of obstructive sleep apnoea (OSA) in females qualified to CPAP treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 200s
Year: 2006

PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment
Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing
Year: 2012

Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome
Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea
Year: 2006

Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009


The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018


Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002

Role of CPAP treatment in elderly with moderate obstructive sleep apnea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019


Control of breathing in obstructive sleep apnoea patients: Role of CPAP therapy
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Effect of multiple-dose treatment with daridorexant on nighttime respiratory function in patients with mild and moderate obstructive sleep apnea (OSA)
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020


Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 103s
Year: 2002

AutoCPAP devices accurately identify obstructive sleep apnea patients with residual apnea during treatment
Source: Annual Congress 2011 - Obstructive sleep apnoea : physiology, diagnostic tools and technology
Year: 2011


Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009

Does personality change in obstructive sleep apnea (OSA) patients using CPAP?
Source: Eur Respir J 2006; 28: Suppl. 50, 409s
Year: 2006

Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006


Health related quality of life after CPAP treatment in patients with obstructive sleep apnoea and patients with overlap syndrome
Source: Eur Respir J 2003; 22: Suppl. 45, 468s
Year: 2003